Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-053246
Filing Date
2025-04-11
Accepted
2025-04-11 16:05:09
Documents
1
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3746
  Complete submission text file 0000950170-25-053246.txt   5255
Mailing Address C/O MERCK & CO., INC. ONE MERCK DRIVE, WS2A-40 WHITEHOUSE STATION NJ 08889
Business Address
Kender Richard N (Reporting) CIK: 0001381205 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 25831548

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)